Featured Research

from universities, journals, and other organizations

First Nations adults have more than double risk of end-stage kidney disease

Date:
December 2, 2013
Source:
Canadian Medical Association Journal
Summary:
First Nations adults with diabetes have more than double the risk of end-stage kidney disease compared with non–First Nations adults, found a new study.

First Nations adults with diabetes have more than double the risk of end-stage kidney disease compared with non-First Nations adults, found a new study in CMAJ (Canadian Medical Association Journal).

Diabetes and high blood pressure are common causes of kidney disease, which can result in end-stage renal disease after years of slow decline in kidney function.

To understand the high rates of end-stage renal disease in First Nations people, researchers looked at all cases of diabetes over 25 years (from 1980 to 2005) in the Canadian province of Saskatchewan. There were 8254 First Nations patients with diabetes whose mean age at diagnosis was 47.2 years; in non-First Nations adults (82 175 people), diabetes was diagnosed at a much older age, with a mean age of 61.6 years. More than 82% of First Nations people had diabetes before age 60, whereas most non-First Nations (56%) were over age 60.

"Because they are younger than non-First Nations individuals when diabetes first develops, First Nations individuals are more likely to survive long enough for end-stage renal disease to occur, presumably because of lower cardiovascular mortality," writes Dr. Roland Dyck, a professor with the departments of Community Health and Epidemiology, and Medicine, University of Saskatchewan, with coauthors.

End-stage renal disease occurred in 2.4% (200) of First Nations people, and 18% (1482) died without end-stage renal disease. In comparison, only 0.7% of non-First Nations people had end-stage renal disease, and 34.6% (28 450) died from other diabetes-related complications. Men were 50% more likely than women to have end-stage renal disease.

"The implications of our findings are sobering," write the authors. "Among First Nations adults, type 2 diabetes is increasingly occurring during younger decades of life. Among First Nations children, the prevalence of diabetes tripled between 1980 and 2005, and the offspring of these individuals are in turn experiencing an even higher risk of childhood type 2 diabetes. …Without substantial improvements in the prevention and treatment of this disease, this pattern will likely translate into increasing numbers of First Nations people with diabetes-related end-stage renal disease and possibly other chronic diabetic complications."

The authors recommend focusing on prevention strategies to reduce the number of new cases of diabetes and to help delay the onset of diabetes.

"For clinicians and administrators, [the] data indicate that the risk of renal disease increases progressively with increasing age. With the onset of diabetes at a younger age among First Nations people, end-stage renal disease is thus a common outcome," writes Dr. Stephen McDonald, School of Medicine, University of Adelaide, Australia, in a linked commentary. "The challenge is not only to provide effective renal replacement therapy, but also to implement more effective primary prevention initiatives to delay the onset of diabetes and the progression of chronic kidney disease."

In a related paper in CMAJ, Alberta researchers found that rates of kidney disease are two to three times higher in First Nations people than in non-First Nations people. However, the association of albuminuria -- the secretion of the protein albumin in urine, which indicates kidney problems -- is similar in both First Nations and non-First Nations people.

"Despite as higher prevalence of heavy albuminuria among First Nations people, we did not find that the presence or severity of albuminuria conferred an additional risk to the development of kidney failure," writes Dr. Brenda Hemmelgarn, Department of Community Health Sciences, University of Calgary, with coauthors. "Even among participants with no measure of albuminuria, risk of progression to kidney failure was similarly elevated for First Nations compared with non-First Nations participants within each category of estimated GFR [glomerular filtration rate]."


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ying Jiang, Nathaniel Osgood, Hyun-Ja Lim, Mary Rose Stang, and Roland Dyck. Differential mortality and the excess burden of end-stage renal disease among First Nations people with diabetes mellitus: a competing-risks analysis. CMAJ, December 2013

Cite This Page:

Canadian Medical Association Journal. "First Nations adults have more than double risk of end-stage kidney disease." ScienceDaily. ScienceDaily, 2 December 2013. <www.sciencedaily.com/releases/2013/12/131202121455.htm>.
Canadian Medical Association Journal. (2013, December 2). First Nations adults have more than double risk of end-stage kidney disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/12/131202121455.htm
Canadian Medical Association Journal. "First Nations adults have more than double risk of end-stage kidney disease." ScienceDaily. www.sciencedaily.com/releases/2013/12/131202121455.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins